Vernalis' collaboration with Tris Latest status of the programmes for the US prescription market.
See at a glance what Vernalis has in development See the status of all programmes,…
Vernalis Research is a world leader in structure- and fragment-based drug discovery.
30 June, 2017 Results
Download our latest report...
14 December, 2017
Our latest presentation is available to view from here...
Share price: 6.15pChange: 0.00 (0.00%)As at: 09 October 2018 22:00:00Volume: 11,077LSE ID: VER
Share price details
T: 0118 938 0000 F: 0118 938 0001Contact informationMaps and directionsContact form
To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and email@example.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch